Underlying features of prostate cancer—statistics, risk factors, and emerging methods for its diagnosis

CV Berenguer, F Pereira, JS Câmara, JAM Pereira - Current Oncology, 2023 - mdpi.com
Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …

Metabolic adaptations in prostate cancer

M Pujana-Vaquerizo, L Bozal-Basterra… - British Journal of …, 2024 - nature.com
Prostate cancer is one of the most commonly diagnosed cancers in men and is a major
cause of cancer-related deaths worldwide. Among the molecular processes that contribute …

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

A Ali, B Mekhaeil, OD Biziotis, EE Tsakiridis… - Communications …, 2023 - nature.com
Radiotherapy is a non-invasive standard treatment for prostate cancer (PC). However, PC
develops radio-resistance, highlighting a need for agents to improve radiotherapy response …

Role of FDG PET/CT in management of patients with prostate cancer

DEK Sutherland, AA Azad, DG Murphy… - Seminars in nuclear …, 2024 - Elsevier
Prostate cancer is the second most common cancer in men worldwide.[18 F] FDG PET/CT
imaging, a well-known and effective technique for detecting malignancies, has not been …

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

YL Xiao, Y Gong, YJ Qi, ZM Shao… - Signal Transduction and …, 2024 - nature.com
Diet, serving as a vital source of nutrients, exerts a profound influence on human health and
disease progression. Recently, dietary interventions have emerged as promising adjunctive …

Raman spectroscopy in prostate cancer: techniques, applications and advancements

F Gaba, WJ Tipping, M Salji, K Faulds, D Graham… - Cancers, 2022 - mdpi.com
Simple Summary Raman spectroscopic analysis is a promising and powerful optical
investigative tool to interrogate tissue and/or biofluids for in vitro and in vivo applications …

Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic …

G Ambrosini, M Cordani, A Zarrabi… - Cell Communication and …, 2024 - Springer
Prostate cancer, as one of the most prevalent malignancies in males, exhibits an
approximate 5-year survival rate of 95% in advanced stages. A myriad of molecular events …

Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers

CL Chen, CY Lin, HJ Kung - International journal of molecular sciences, 2021 - mdpi.com
Increasing evidence suggests that tumor development requires not only oncogene/tumor
suppressor mutations to drive the growth, survival, and metastasis but also metabolic …

Clinical applications of liquid biopsy in prostate cancer: from screening to predictive biomarker

F Ionescu, J Zhang, L Wang - Cancers, 2022 - mdpi.com
Simple Summary Liquid biopsy (LB), encompassing the analysis of circulating tumor
material in the blood or urine, has emerged as a powerful tool in the management of …

Global trends of cancer: The role of diet, lifestyle, and environmental factors

H Bahrami, M Tafrihi - Cancer Innovation, 2023 - Wiley Online Library
Effective treatment of cancer requires understanding the nature of the disease and
accurately addressing the main root causes. General risk factors for cancer include poor …